EP3019490
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.7.2014EP published:
3.6.2020EP application number:
14745309.6
EPO information:
European Patent Register
Max expiry date:
9.7.2034
Title:
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
Timeline
Today
10.7.2014EP application
3.6.2020EP Publication
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
TRAVINS, JeremyAddress:
Southborough, MA 01772, US
Name:
UTLEY, LukeAddress:
Milford, NH 03055, US
Priority
Number:
201361845352 PDate:
11.7.2013Country:
US
Classification
Categories:
C07D 401/14, C07D 401/04, C07D 401/12, C07D 403/12, C07D 403/04, C07D 413/12, C07D 417/12, C07D 417/14, C07D 251/18, A61K 31/53, A61P 35/00